ABBOTT LABORATORIES

NeuroTherm Radiofrequency Generator System

NT500 , NT1100 and NT2000iX Notice of Service Discontinuation Sept 2021

Notice of Service Discontinuation

1 Page

Abbott Neuromodulation Da Vincilaan Box11, F1 1935 Zaventem Belgium  Customer Notification September 2021  Subject:  Notice of service discontinuation  Affected Product(s):  Model Number  Product Description  RFG-NT-500  NT500™ RF Generator  RFG-NT-1100  NT1100™ RF Generator  RFG-NT-2000  NT2000iX™ RF Generator  Dear Abbott Customer, You have received this letter because you have purchased an RF Neurotherm generator from Abbott in the past. Abbott consistently reviews the products and services that we offer and has made the decision to discontinue servicing of the Neurotherm generators from September 2022 onwards. Meanwhile we have manufactured a new generator, the IonicRF™ generator. The IonicRF™ Generator’s was developed with two goals in mind. To combine optimal system reliability with highefficiency performance. Careful thought is on display throughout every aspect of the IonicRF™ Generator’s design and functionality. Its ergonomic form, intuitive user interface and streamlined navigation enable teams to quickly become proficient. The IonicRF™ Generator is compatible with Abbott’s existing line of needles and electrodes. If you have any questions regarding this change or want to learn more about the IonicRF™ Generator, please contact your local Abbott Representative or Abbott Customer Service. We apologize for any inconvenience that this may cause. Please know that Abbott values your business and is committed to providing the highest quality products and support, and we are committed to helping you identify the best solution moving forward. Sincerely,  Sylvain Lacomble, PhD Head of International Marketing, EMEA & APAC
File Type: PDF
File Size: 98.1 KB
File Name: NT500 , NT1100 and NT2000iX Notice of Service Discontinuation Sept 2021.pdf

By clicking Download you are confirming this is the correct document for your purposes
and that you agree to our Terms & Conditions